Related Experiment Videos
[Congenital long QT syndrome]
J M Lupoglazoff1, I Denjoy, N Neyroud
1Service de Cardiologie infantile, Hôpital Robert Debré, Paris. jean-marc.lupoglazof@rdb.ap-hop-paris.fr
Presse Medicale (Paris, France : 1983)
|October 13, 1998
Summary
Congenital long QT syndrome (LQTS) is a genetic heart condition causing dangerous arrhythmias and sudden death. Early genetic testing and screening are vital for affected families.
Area of Science:
- Cardiology
- Genetics
- Molecular Biology
Context:
- Congenital long QT syndrome (LQTS) is a heterogeneous genetic disorder.
- Characterized by ECG-prolonged QT interval, risk of ventricular arrhythmias (torsades de pointes, ventricular fibrillation), syncope, and sudden death.
- Occurs in individuals with structurally normal hearts, transmitted via autosomal dominant or recessive inheritance.
Purpose:
- To highlight the clinical and genetic heterogeneity of LQTS.
- To emphasize the importance of screening tests due to the condition's severe prognosis.
- To underscore the role of genetic identification in understanding adrenergic ventricular rhythm disorders.
Summary:
- LQTS presents diverse clinical and genetic forms, including deafness association and varying inheritance patterns.
- Genetic studies have identified at least 5 loci and 4 genes implicated in LQTS, illustrating adrenergic ventricular rhythm disorders.
- Beta-blockers are the primary treatment for symptomatic patients.
Impact:
- Contraindication of QT-prolonging drugs for individuals with genetic anomalies.
- Mandatory Holter monitoring and genetic testing for all direct family members to identify mutation carriers or asymptomatic individuals.
- Early identification and management are crucial for preventing sudden cardiac death in LQTS families.